Merck KGaA's subsidiary MilliporeSigma has developed a first-of-its-kind “all-in-one” CHO genetic stability assay, according ...
A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...
Bruker Corporation has emerged as the winner of an auction for NanoString Technologies and its spatial biology assets after the company filed for Chapter 11 bankruptcy earlier this year. | Bruker has ...
Vertex Pharmaceuticals has inched closer to bringing a new, non-opioid med to the blockbuster pain market, with the FDA ...
The trees have been trimmed, branches pruned, underbrush cleared away. | A thinner, leaner biotech forest arrived at the ...
The number of biopharma M&A deals more than doubled in the first quarter of 2024 compared to the same period a year ago, ...
23andMe’s co-founder and CEO Anne Wojcicki has put in motion a plan to take the company private after the stock value of the ...
The backing singer in AbbVie’s $8.7 billion takeover of Cerevel Therapeutics is having its moment in the spotlight. | The ...
Clinical-stage Metsera has emerged from stealth with $290 million in hand and the bold vision of ushering in the next ...
Charles River Laboratories has launched a new project to cut down on animal testing in drug discovery. | Charles River ...
Scopio Labs has received a de novo clearance from the FDA for its artificial-intelligence-powered system that analyzes bone ...
Abbott saw large gains in its medical device sales that helped push its revenues to just shy of $10 billion—exceeding the ...